memo—new frontiers to be reached

With the publication of issue 4/2015 of memo in December 2015, memo finished its eighth year. Many experts, first of all the members of the editorial board (acting as authors and/or reviewers), have always actively supported memo to ensure the high quality memo has always offered to its readership. Therefore, we want to express our gratitude and thank everyone for contributing to memo’s success!

memo was founded in 2008 and the first year was entirely devoted to a lot of administrative and organizational work to get the first issue of memo published in autumn 2008. Considering memo’s development, it can be stated that the first years were busy with establishing a reliable pool of authors and reviewers and collecting manuscripts of high quality. To boost memo’s way to internationality, section editors coming from different nations were established (2 Austria, 1 Hungary, 1 Switzerland, 1 Russia) and the editorial board could be extended to many European countries and new frontiers were opened (Israel, Iran, USA).

Looking back—What are memo’s achievements so far?

• memo is the official journal of societies and study groups (CECOG—since 2008; and OeGHO—since 2012)

• memo presents updates of various important conventions, such as ASH, ASCO, etc.

• memo discusses many hot spots in our field and offers an interdisciplinary platform of communication

• memo is included in the following indexing services: SCOPUS, EMBASE, Google Scholar, Academic OneFile, Expanded Academic, Health Reference Center Academic, OCLC, SCImago, Summon by Serial Solutions

• memo is read all over the world: displayed by a full-text download frequency of 9000 per year, the readers come from Europe, America, and Asia-Pacific 1/3 each.

To continue this positive development and strive for getting listed in PubMed in the near future, it is already high time to think about memo’s coming issues. What would be interesting for our readers, then?

For the next years, our experts from the editorial board and our readers asked us to give special focus to the following topics:

• Smoking and its role in oncology

• New challenges in stem cell transplantation

• Secondary malignancies after prior chemotherapy or organ transplantation

• Drawbacks of targeted therapies—back to bench

• Molecular basis of new therapeutic targets

• Sarcomas: an interdisciplinary challenge

• Colorectal cancer, still a long way to cure

• New development in melanoma treatment

• Palliative care—more than end-of-life attendance

• Quality of life—the unknown endpoint—interpretation, and clinical consequences

• Solid tumors in children

• Neoadjuvant strategies in gastrointestinal cancer

• Follow-up—scientific background for rationale recommendations

Through the contributions of the editorial board members, authors, and reviewers the future development of MEMO can be equally fruitful.

Therefore,

• 1. your feedback to Editor-in-Chief Prof. Hilbe is appreciated;

• 2. your proposal of experts of who should be invited is necessary; and

• 3. your motivation of colleagues to submit their manuscripts is essential.

Counting on you and looking forward to many more interesting issues of memo

Prof. Dr. Wolfgang Hilbe

Editor-in-Chief, memo magazine of european medical oncology

Waltraud Radlherr

(memo Secretary)

memo-secretary@springer.at